SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

M7T Mach7 Technologies Limited

Healthcare · Health Information Services · website
$0.23
52wk 0.22 – 0.69
Overall
39.2
Value
92.0
Growth
0.0
Health
84.1
Quality
0.0
Momentum
0.5
Dividend
—
Price
About Mach7 Technologies Limited

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. Mach7 Technologies Limited was founded in 2007 and is headquartered in Melbourne, Australia.

Price analytics

Returns

1 day 0.0%
1 week -2.1%
1 month -22.0%
3 months -25.8%
6 months -29.2%
1 year -28.1%
3 years -68.7%

Risk

Volatility (1y ann.) 65.3%
Beta vs ASX 200 1.24
Sharpe (1y) -0.25
VaR 95% (1-day) -6.2%
Max drawdown (1y) -66.9%
Off 1-year high -66.2%

Technicals

RSI(14) 41
vs 50DMA -14.2%
vs 200DMA -31.0%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 92.0
Trailing P/E
—
Forward P/E
100
PEG ratio
75
EV / EBITDA
100
Price / Book
92
Price / Sales
88
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 84.1
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
64
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 0.5
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
2

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$54.05M
P/E (trailing)
—
P/E (forward)
-12.53
EPS (trailing)
-0.04
Dividend yield
—
Payout ratio
0.0%
Beta
0.97
EV / EBITDA
-4.64
Price / Book
1.56
ROE
-22.3%
Operating margin
-14.0%
Net margin
-31.9%
Total cash
$19.92M
Total debt
$80,393
Current ratio
1.89
Debt / Equity
0.00
Free cash flow
$1.11M
Avg volume
85,493
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$17.24M
  • Gross profit$15.80M
  • Operating income-$22.34M
  • Net income-$7.97M
  • Diluted EPS-0.03
  • Free cash flow$3.06M
  • Net debt-$24.91M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4